Contact Us Global About Amicus ❯ Leadership ❯ Board of Directors A Passionate Team with a Purpose We are driven toward invention and healing. Committed to delivering meaningful benefits to the rare and orphan disease community, our dedicated leadership team is the driving force behind our developments. They are constantly inspired by others in the rare disease community, and continually aspire to reach new heights. Senior Management Team Board of Directors John F. Crowley Chairman of the Board, Chief Executive Officer Bradley L. Campbell President and Chief Operating Officer Lynn D. Bleil Director Robert Essner Director Michael A. Kelly Director Margaret G. McGlynn Director Michael G. Raab Director Eiry W. Roberts, M.D. Director Glenn P. Sblendorio Director Craig A. Wheeler Director Burke W. Whitman Director About Amicus Chairman’s Welcome Leadership Belief Statement Contact Us Message from BIO Patient Advocacy Disease Information Rare Stories Patient Advisory Boards Corporate Giving Resources Expanded Access Programs & Pipeline Pipeline Our Programs Clinical Trials Product Overview Amicus Assist™ Responsibility Ethics & Compliance Global Medical Affairs Corporate Giving Healing Beyond Disease ESG Report Investors & Media Corporate Governance Press Releases Events & Presentations Annual Reports & Proxies SEC Filings Stock Performance Investor FAQs Featured Coverage Careers Overview Who We Are Search Social Media Twitter YouTube LinkedIn Copyright © 2021 Amicus Therapeutics, Inc. All rights reserved. NP-AT-ALL-00011119 Cookies Statement Terms of Use Privacy Notice Amicus Therapeutics informs you that our website uses its own and third party cookies to improve our services and collect statistical information about your browsing. By clicking accept, we consider that you accept its use. For more information, or to know how to change the configuration, consult our Privacy Policy. Accept